2024 Global Sexually Transmitted Disease STD Market
This new report from contains analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report is available by section, and can be customized to specific information needs and budget.
The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for:
AIDS/HIV
Chancroid
Chlamydia
Gonorrhea
Granuloma Inguinale
Herpes I/II
Lymphogranuloma
Mycoplasma
Papillomavirus
Syphilis
Trichomonas Vaginalis
The report provides test volume and sales forecasts by country and market segment, including:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted." "
This new report from contains analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report is available by section, and can be customized to specific information needs and budget.
The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for:
AIDS/HIV
Chancroid
Chlamydia
Gonorrhea
Granuloma Inguinale
Herpes I/II
Lymphogranuloma
Mycoplasma
Papillomavirus
Syphilis
Trichomonas Vaginalis
The report provides test volume and sales forecasts by country and market segment, including:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted."
II. Worldwide Market and Technology Overview
A. Major STD Tests
1. AIDS/HIV
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Lymphogranuloma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review
C. Emerging Diagnostic Technologies
III. Country Test Volume and Sales Forecasts,
Supplier Shares
France: Sales Forecasts and Supplier Shares
Germany: Sales Forecasts and Supplier Shares
Italy: Sales Forecasts and Supplier Shares
Japan: Sales Forecasts and Supplier Shares
Spain: Sales Forecasts and Supplier Shares
UK: Sales Forecasts and Supplier Shares
USA: Sales Forecasts and Supplier Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Competitive Assessments
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman
Coulter/Cepheid/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
GSK Biologicals
Hologic
Illumina
LabCorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Lonza
Myriad Genetics
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
SeraCare
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako
2024 US Hepatitis Diagnostics Market Supplier Shares
2024 US Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for
USD 2500 View Report2024 UK Hepatitis Diagnostics Market Supplier Shares
2024 UK Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for
USD 2500 View Report2024 Global Hepatitis Diagnostics Market Supplier Shares
2024 Global Hepatitis A, B, C, D, E Diagnostics Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review,
USD 4750 View Report2024 Global Flow Cytometry Reagents Analyzers US
2024 Global Flow Cytometry Reagents and Analyzers: US, Europe, Japan--Supplier Shares and Strategies, Technology and Instrumentation Review, Emerging OpportunitiesThis 7-country report will help current suppliers and potential market entrants identify
USD 18500 View ReportFill The Form For Sample Request